Type
Stravens M. Lepra: de laatste zet. Vice Versa. 2015;49(4):30 - 33.
Type
Raicher I, Stump PRNAG, Baccarelli R, Marciano L, Ura S, Virmond M, et al. Neuropathic pain in leprosy. Clinics in dermatology. 2016;34(1):59-65.
Type
Garbino JA, Heise CO, Marques W. Assessing nerves in leprosy. Clinics in dermatology. 2016;34(1):51-58.
Type
Naafs B, Hees C. Leprosy type 1 reaction (formerly reversal reaction). Clinics in dermatology. 2016;34(1):37-50.
Type
Noordeen S. History of chemotherapy of leprosy. Clinics in dermatology. 2016;34(1):32-36.
Type
Schreuder P, Noto S, Richardus JH. Epidemiologic trends of leprosy for the 21st century. Clinics in dermatology. 2016;34(1):24-31.
Type
Cruz A. Leprosy as a multilayered biosocial phenomenon: The comparison of institutional responses and illness narratives of an endemic disease in Brazil and an imported disease in Portugal. Clinics in dermatology. 2016;34(1):16-23.
Type
Grzybowski A, Sak J, Pawlikowski J, Nita M. Leprosy: Social implications from antiquity to the present. Clinics in dermatology. 2016;34(1):8-10.
Type
Grzybowski A, Nita M. Leprosy in the Bible. Clinics in dermatology. 2016;34(1):3-7.
Type
Zhang F, Liu H, Chen S, Low H, Sun L, Cui Y, et al. Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nature genetics. 2011;43(12):1247-51.